[go: up one dir, main page]

DK0701604T3 - Immortalisering af dendritiske celler med V-myc-onkogenet - Google Patents

Immortalisering af dendritiske celler med V-myc-onkogenet

Info

Publication number
DK0701604T3
DK0701604T3 DK94917670T DK94917670T DK0701604T3 DK 0701604 T3 DK0701604 T3 DK 0701604T3 DK 94917670 T DK94917670 T DK 94917670T DK 94917670 T DK94917670 T DK 94917670T DK 0701604 T3 DK0701604 T3 DK 0701604T3
Authority
DK
Denmark
Prior art keywords
pct
dendritic cells
immortalization
myc oncogene
sec
Prior art date
Application number
DK94917670T
Other languages
Danish (da)
English (en)
Inventor
Francesca Granucci
Original Assignee
Biotop S A S Di Rita Cassarin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotop S A S Di Rita Cassarin filed Critical Biotop S A S Di Rita Cassarin
Application granted granted Critical
Publication of DK0701604T3 publication Critical patent/DK0701604T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/19—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4242—Transcription factors, e.g. SOX or c-MYC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK94917670T 1993-05-31 1994-05-26 Immortalisering af dendritiske celler med V-myc-onkogenet DK0701604T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT93MI001118A IT1264516B1 (it) 1993-05-31 1993-05-31 Cellule dendritiche immortalizzate
PCT/EP1994/001720 WO1994028113A1 (fr) 1993-05-31 1994-05-26 Immortalisation de cellules dendritiques avec l'oncogene v-myc

Publications (1)

Publication Number Publication Date
DK0701604T3 true DK0701604T3 (da) 1999-07-26

Family

ID=11366291

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94917670T DK0701604T3 (da) 1993-05-31 1994-05-26 Immortalisering af dendritiske celler med V-myc-onkogenet

Country Status (15)

Country Link
US (2) US5856180A (fr)
EP (1) EP0701604B1 (fr)
JP (1) JP3834059B2 (fr)
KR (1) KR100353220B1 (fr)
AT (1) ATE173294T1 (fr)
AU (1) AU686636B2 (fr)
CA (1) CA2164102A1 (fr)
DE (1) DE69414572T2 (fr)
DK (1) DK0701604T3 (fr)
ES (1) ES2126118T3 (fr)
GR (1) GR3029374T3 (fr)
HU (1) HUT73322A (fr)
IT (1) IT1264516B1 (fr)
WO (1) WO1994028113A1 (fr)
ZA (1) ZA943782B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4337396A1 (de) 1993-10-26 1995-04-27 Beiersdorf Ag Humane Zellinien mit Langerhans-Zell-Charakteristik
US5648219A (en) * 1995-06-07 1997-07-15 Zymogenetics, Inc. Immortalized dendritic cells
US5648248A (en) * 1994-12-30 1997-07-15 Boehringer Ingelheim International Gmbh Methods for producing differentiated cells from immature hematopoietic cells
US5723333A (en) * 1995-02-10 1998-03-03 Regents Of The University Of California Human pancreatic cell lines: developments and uses
AU716854B2 (en) * 1995-02-10 2000-03-09 Regents Of The University Of California, The Human pancreatic cell lines: developments and uses
AU4977896A (en) * 1995-02-17 1996-09-04 Immunotherapy, Inc. Immunotherapy screening, prognosis, and treatment methods and compositions
US5849589A (en) * 1996-03-11 1998-12-15 Duke University Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells
US6017527A (en) * 1996-07-10 2000-01-25 Immunex Corporation Activated dendritic cells and methods for their activation
AU705647B2 (en) * 1996-07-10 1999-05-27 Immunex Corporation Method of activating dendritic cells
US20050169898A1 (en) * 1997-04-15 2005-08-04 Jianlin Gong Cell fusions and methods of making and using the same
DE69839215T2 (de) 1997-04-15 2009-03-19 Dana-Farber Cancer Institute, Inc., Boston Dendritische zellhybride
AU3102799A (en) * 1998-03-20 1999-10-11 Genzyme Corporation Enhanced anti-tumor immunity
US7014848B1 (en) 1998-03-20 2006-03-21 Genzyme Corporation Enhanced anti-tumor immunity
US7402307B2 (en) 1998-03-31 2008-07-22 Geron Corporation Method for identifying and killing cancer cells
CA2347067C (fr) 1998-03-31 2013-09-17 Geron Corporation Vaccin a base de cellule dendritique contenant de la transcriptase inverse de la telomarase pour le traitement du cancer
US6387888B1 (en) 1998-09-30 2002-05-14 American Foundation For Biological Research, Inc. Immunotherapy of cancer through expression of truncated tumor or tumor-associated antigen
MXPA03005373A (es) * 2000-12-13 2004-03-26 Inmunex Corp Metodo para generar lineas celulares dentriticas inmortales.
IL160142A0 (en) 2001-08-17 2004-06-20 Anosys Inc Methods and compounds for the targeting of protein to exosomes
US8095735B2 (en) 2008-08-05 2012-01-10 Convey Computer Memory interleave for heterogeneous computing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648219A (en) * 1995-06-07 1997-07-15 Zymogenetics, Inc. Immortalized dendritic cells
US5648248A (en) * 1994-12-30 1997-07-15 Boehringer Ingelheim International Gmbh Methods for producing differentiated cells from immature hematopoietic cells

Also Published As

Publication number Publication date
CA2164102A1 (fr) 1994-12-08
US6156307A (en) 2000-12-05
HUT73322A (en) 1996-07-29
ZA943782B (en) 1995-02-09
KR100353220B1 (ko) 2003-12-31
IT1264516B1 (it) 1996-09-24
HU9503414D0 (en) 1996-01-29
JPH09500523A (ja) 1997-01-21
WO1994028113A1 (fr) 1994-12-08
EP0701604B1 (fr) 1998-11-11
ITMI931118A0 (it) 1993-05-31
GR3029374T3 (en) 1999-05-28
US5856180A (en) 1999-01-05
DE69414572T2 (de) 1999-07-29
ES2126118T3 (es) 1999-03-16
ATE173294T1 (de) 1998-11-15
ITMI931118A1 (it) 1994-12-01
JP3834059B2 (ja) 2006-10-18
EP0701604A1 (fr) 1996-03-20
DE69414572D1 (de) 1998-12-17
AU6929994A (en) 1994-12-20
AU686636B2 (en) 1998-02-12

Similar Documents

Publication Publication Date Title
DK0701604T3 (da) Immortalisering af dendritiske celler med V-myc-onkogenet
PT716689E (pt) Processo para a preparacao e cultura de celulas progenitoras hematopoieticas
ES2146611T3 (es) Tejido cartilaginoso reconstituido.
DE69535328D1 (de) In-vitro wachstum von langerhans'schen inseln und ihre verwendungen
ES2160116T3 (es) Modelo de equivalente de cornea producido in vitro.
DE69734605D1 (de) Abgeschwächter salmonellenstamm, gebraucht als vehikel zur oralen immunisierung
ZA969489B (en) Novel transfection agents and their pharmaceutical applications
DK0414475T3 (da) Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier
DK0789588T3 (da) Metode til fremstilling af et medikament til behandling af sekundær immundefekt
EP0525005A4 (en) Method for inhibiting cell growth and compositions useful therefor
DK0688365T3 (da) Regulering af fertilitet med transformerende vækstfaktor-beta
DK0865498T3 (da) Fremgangsmåde til fremstilling af substituerede arylmælkesyreholdige cyclodepsipeptider med 24 ringatomer
DK0868437T3 (da) Fremgangsmåde til fremstilling af hyaluronsyrefraktion med et lavt polydispersionsindeks
PL327200A1 (en) Endothelium cells proliferation inhibitor and methods of using same
CA2146735A1 (fr) Cellules parenchymateuses du foie capables de croissance clonale, methode pour les obtenir et pour en faire des sous-cultures, et systeme de sous-culture d'hepatocytes primaires
DK1456238T3 (da) Produktion af F(ab')2-fragmenter i pattedyrceller
DE69333547D1 (de) Therapeutische anwendungen von chimänischer organogenese
ES2160829T3 (es) Procedimiento para la obtencion de riboflavina por medio de microorganismos con actividad de isocitratoliasa modificada.
BR0008536A (pt) Usos de um meio de cultura, e de pelo menos um mas, análogo de mas ou um aditivo ou aditivos, e, processo para fertilização in vitro
ES2163001T3 (es) Nuevos derivados de borneol, procedimiento para su preparacion y su utilizacion farmaceutica.
DK0898708T3 (da) Interaktion af cyclin D1 og estrogenreceptor og anvendelse deraf i assays
DK0680467T3 (da) Fremgangsmåde til fremstilling af C-substituerede diethylentriaminer
Chotard‐Ghodsnia et al. Cyclic AMP‐dependent cell shape changes induced by mechanical forces
ES2106361T3 (es) Procedimiento para la modificacion de polimeros.
PT83368A (en) Process for propagating microorganisms in vivo by using cell lines which lack human class ii histocompatibility antigens